Abstract
Accepted 31 December 1996
The aim of the study was to define the respiratory morbidity caused by lymphocytic interstitial pneumonitis (LIP) in children with vertically acquired HIV infection. A retrospective case note review was performed on 95 children attending three London hospitals. Clinical and radiological evidence of LIP, acute lower respiratory tract infections, and chronic lung disease was obtained using a structured protocol. A diagnosis of LIP had been made in 33%, and an acute admission due to acute lower respiratory tract infection had occurred in 42% of all children (despite 99% taking regular co-trimoxazole prophylaxis). Admission rates because of acute lower respiratory tract infection were significantly higher in the LIP group (0.38 admissions/child year) than in the non-LIP group (0.17 admissions/child year) (p = 0.0002). Encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae) were most frequently isolated. Improved methods of prevention of acute lower respiratory tract infection may help to reduce the severe respiratory morbidity seen in children with LIP and HIV infection.
Full Text
The Full Text of this article is available as a PDF (99.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andiman W. A., Eastman R., Martin K., Katz B. Z., Rubinstein A., Pitt J., Pahwa S., Miller G. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet. 1985 Dec 21;2(8469-70):1390–1393. doi: 10.1016/s0140-6736(85)92557-7. [DOI] [PubMed] [Google Scholar]
- Denny F. W., Clyde W. A., Jr Acute lower respiratory tract infections in nonhospitalized children. J Pediatr. 1986 May;108(5 Pt 1):635–646. doi: 10.1016/s0022-3476(86)81034-4. [DOI] [PubMed] [Google Scholar]
- Joshi V. V., Oleske J. M. Pulmonary lesions in children with the acquired immunodeficiency syndrome: a reappraisal based on data in additional cases and follow-up study of previously reported cases. Hum Pathol. 1986 Jun;17(6):641–642. doi: 10.1016/s0046-8177(86)80143-5. [DOI] [PubMed] [Google Scholar]
- Katz B. Z., Berkman A. B., Shapiro E. D. Serologic evidence of active Epstein-Barr virus infection in Epstein-Barr virus-associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome. J Pediatr. 1992 Feb;120(2 Pt 1):228–232. doi: 10.1016/s0022-3476(05)80432-9. [DOI] [PubMed] [Google Scholar]
- Krasinski K., Borkowsky W., Bonk S., Lawrence R., Chandwani S. Bacterial infections in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1988 May;7(5):323–328. doi: 10.1097/00006454-198805000-00006. [DOI] [PubMed] [Google Scholar]
- Mofenson L. M., Moye J., Jr Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection. Pediatr Res. 1993 Jan;33(1 Suppl):S80–S89. doi: 10.1203/00006450-199305001-00464. [DOI] [PubMed] [Google Scholar]
- Pitt J. Lymphocytic interstitial pneumonia. Pediatr Clin North Am. 1991 Feb;38(1):89–95. doi: 10.1016/s0031-3955(16)38044-0. [DOI] [PubMed] [Google Scholar]
- Rubinstein A., Bernstein L. J., Charytan M., Krieger B. Z., Ziprkowski M. Corticosteroid treatment for pulmonary lymphoid hyperplasia in children with the acquired immune deficiency syndrome. Pediatr Pulmonol. 1988 Jan-Feb;4(1):13–17. doi: 10.1002/ppul.1950040105. [DOI] [PubMed] [Google Scholar]